| |
|
|
|
INmune Bio Inc.  
|
|
10.31 -0.69 (-0.06%) |
09-30 16:00 |
|
Open: |
10.88 |
Pre close: |
11 |
Target:
|
14.37 
|
|
High: |
11.03 |
Low: |
10.16 |
Resistance:
|
12.30
14.37
|
|
Volume: |
103,688 |
Market Cap: |
139M |
Support:
|
9.85
8.34
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.67
|
MACD |
MACD(12,26):
|
0.25 |
|
MA(20): |
10.39 |
Signal(12,26,9): |
0.21 |
|
MA(100): |
8.47 |
Stochastic Oscillator |
%K(14,3):
|
57.86 |
|
MA(250): |
6.14 |
%D(3): |
56.42 |
|
Average Volume(K) |
3-Month: |
123352
|
52-Week |
High:
|
24.42 |
|
10-Days: |
18518 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
57.12 |
Change(%): |
104.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.890 |
Return on Equity (ttm) |
-39.4 |
Shares Out. (M) |
13.45 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-23.8 |
Shares Float (M) |
6.69 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
58.23 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.60 |
|
Forward EPS |
-0.750 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
354 |
|
Book Value (p.s.) |
1.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-12.65 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.66 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.23 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-1.90 |
P/CF |
-28.96 |
|
|
|
|
|
|
